Author: A. Ant, CADC-II, Licensing & Accreditation Expert
Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.
Certification details: DSU Treatment Provider Certification | Questions: 802-651-1550
Outpatient substance use disorder treatment in Vermont, intensive outpatient included, sits outside the Therapeutic Community Residence license that DAIL’s Division of Licensing and Protection issues to residential programs. That license is written for a place giving treatment to “three or more residents,” and an outpatient clinic has no residents. What outpatient operators deal with instead is certification from the Vermont Department of Health’s Division of Substance Use Programs (DSU), and the part people coming from one-license states usually miss is who that certification rule actually reaches.
No Facility License, and Certification Follows the Funding
DSU’s Substance Use Disorder Treatment Certification Rule (Department of Health, Chapter 8, Subchapter 4, effective January 1, 2020) states that certification “is required for any substance use disorder treatment program that receives state or federal funding from the Department.” Vermont calls a certified program a Preferred Provider once it also has a Department contract or grant. A certificate lasts no more than three years, renewal applications are due at least 60 days before it expires, and DSU’s treatment standards require a site visit at every service location before a certificate is issued. The rule does not create a separate license for a privately funded outpatient clinic, and we have not found one anywhere else in Vermont law. Our reading, which you should confirm with DSU before relying on it, is that a clinic taking no Department money is not directly required to certify. Certification still shapes hiring, though. The Office of Professional Regulation’s counselor FAQ says “Affiliation with a DSU Certified Provider is required to obtain an AAP or ADC credential,” so an uncertified clinic can’t build its counselor team on those two credentials.
Which Outpatient Levels DSU’s Standards Cover
DSU’s Preferred Provider Substance Use Disorder Treatment Standards are organized around ASAM Criteria levels of care, and their residential definitions point to the Third Edition. They define outpatient (ASAM Level 1) as an organized nonresidential service or office practice, “usually totaling fewer than nine (9) contact hours per week.” Intensive outpatient (Level 2.1) gets its own section, 21.0, which calls for at least 9 and no more than 19 direct contact hours a week for adults (6 or more for adolescents), at least two of individual, group, or family counseling or case management each week, and a direct affiliation or referral link to more and less intensive care. Section 11.0 limits each provider to “the specific levels of care and associated services, at specific sites, approved and certified by DSU.” The current standards contain no section for partial hospitalization (Level 2.5) or for ambulatory withdrawal management, and they describe withdrawal management as a service in a facility staffed 24 hours a day. If either service is in your plan, ask DSU how it would be reviewed before you staff for it.
Certificate of Need and Outpatient Projects
Outpatient programs aren’t exempt from Certificate of Need by category. The definition of “health care facility” in 18 V.S.A. § 9432 lists “outpatient diagnostic or therapy programs,” and the Green Mountain Care Board docket includes a 2020 jurisdictional filing for an outpatient SUD treatment center (River Rock Treatment Center, GMCB-007-20con). The dollar thresholds are what keep most clinics out. Act 15 of 2025, effective on passage on May 13, 2025, raised the § 9434 thresholds, which apply to hospitals and every other health care facility alike, to a capital cost above $10,000,000, equipment above $5,000,000, or a new service with annual operating expense above $3,000,000 in either of the next two budgeted fiscal years, and GMCB may adjust those figures for inflation. The Board’s 2026 CON Bulletin 004 (February 1, 2026) lists the adjusted amounts, and because we could not open it, get the current numbers from GMCB directly. Section 9435(g) separately excludes, with the Commissioner of Health’s approval, a facility where prescribing, dispensing, or administering medication for opioid use disorder is a principal activity. When a project is close to a line, GMCB accepts a Request for Jurisdictional Determination at gmcb.con@vermont.gov.
Medication for Opioid Use Disorder in Outpatient Care
Most opioid use disorder care in Vermont runs through the Hub and Spoke system. The Blueprint for Health describes Hubs as “specialized centers for treating opioid use disorder” that offer daily medication and therapy, and Spokes as “Office Based Opioid Treatment settings,” mostly primary care or family medicine practices. DSU’s standards use the same vocabulary: opioid treatment programs (OTPs) are the Hubs, office-based opioid treatment (OBOT) providers are the Spokes. An OTP needs federal certification, which in turn requires a current accreditation from an accreditation body or other entity designated by the HHS Secretary under 42 CFR 8.11, and § 8.11(e)(1) keeps state rules in force on top of that.
The state layer is the Department of Health’s Rules Governing Medications for Opioid Use Disorder, effective May 15, 2024 and adopted under 18 V.S.A. § 4752, which covers OBOT providers and OTPs in one rule. An OTP that wants a medication unit (a dispensing site that is part of the OTP but geographically separate from it) needs Department approval first under § 7.2. The rule sets no cap on how many patients an office-based prescriber may treat, and DEA’s January 2023 letter to registrants says there are no longer any federal patient limits for buprenorphine either. OBOT prescribers do have to register with and query the Vermont Prescription Monitoring System, and a pregnant person who asks an OBOT for MOUD has to be admitted or referred to an OTP within 48 hours of first contact (§ 6.8.1). Section 20.0 of DSU’s standards adds that Preferred Providers offering MOUD must also follow the Department’s MOUD rules.
Federally, Section 1262 of the Consolidated Appropriations Act, 2023 ended the buprenorphine waiver, and DEA now says prescriptions for buprenorphine “only require a standard DEA registration number.” Separately, every DEA-registered practitioner other than a veterinarian who files a new or renewal registration on or after June 27, 2023 has to attest, by checking a box on the form, to a one-time total of eight hours of training on treating substance use disorders. Our recommendation for an outpatient program adding buprenorphine or naltrexone is to operate as a Spoke or in written coordination with the regional Hub, rather than running medication management as a separate line of its own.
Opening a Ketamine Clinic in Vermont
Vermont has no ketamine clinic rule. Parts of this section describe what the law leaves out, and those parts are our reading, not something an agency has confirmed.
In licensing terms, a Vermont clinic giving ketamine for depression is a medical practice. It has no residents, so the Therapeutic Community Residence license doesn’t reach it, and DSU certification follows Department funding for substance use treatment, which a ketamine clinic doesn’t receive for ketamine. We found no other facility license that would apply. What does apply is personal licensure for each prescriber and the federal controlled substance rules. Ketamine is Schedule III (21 CFR 1308.13(c)(7)), and 21 CFR 1301.12 requires a separate DEA registration for each location where it is stored and given; the exception for an office where drugs are only prescribed doesn’t fit a clinic that keeps vials. For esketamine, the FDA labeling limits Spravato to REMS-certified healthcare settings and requires at least 2 hours of monitoring after each dose.
Ownership and Who Can Run It
Vermont doesn’t push a ketamine clinic into the physician-owned-practice-plus-MSO structure that stricter states require. The professional corporation statute, 11 V.S.A. chapter 3, lets licensed people incorporate (§ 802), allows shares to be issued “only to persons who are duly licensed” (§ 805) and requires professional services to be delivered through licensed officers, employees and agents (§ 807). It’s permissive, though. We found no Vermont statute, rule or court decision barring a lay-owned company from owning a medical practice or employing physicians, so a PC with a management services agreement is one option rather than the required one.
That nearly changed in 2026. Early drafts of H.583 would have made it unlawful for an entity without a medical license to own a medical practice or employ licensees. The enacted version dropped that and instead adds 18 V.S.A. chapter 233: a private equity group or hedge fund involved with a health care facility may not interfere with providers’ clinical judgment or control things like clinical standards, clinical staffing levels or the prices charged for a provider’s services, while unlicensed parties can still provide nonclinical management and administrative services as long as a licensed provider keeps ultimate responsibility. The governor approved it on June 15, 2026 as Act 133, and it took effect July 1, 2026. For a clinic with ordinary lay investors it changes little. A clinic backed by a private equity fund should write its management agreement with chapter 233 in mind.
Nurse practitioners can lead much of the work. Under 26 V.S.A. § 1613, an APRN with fewer than 24 months and 2,400 hours of practice in an initial role needs a formal agreement with a collaborating provider and can’t practice solo; once past that, the APRN notifies the Board and can practice independently in that role. On prescription monitoring, the VPMS rule (its July 2017 version, the newest we could find) exempts drugs “administered directly to a patient” from reporting (section 4.5.1), while a clinic that dispenses take-home ketamine reports like any dispensing prescriber (section 4.4).
If a DSU-certified outpatient program wants ketamine in the same building, keep the two separate in records, staffing and drug supply, since the program’s certificate covers only the levels of care and associated services DSU approved. How a residential program starts ketamine and hands it off to a clinic like this one is covered in the ketamine section of Vermont Drug and Alcohol Inpatient Treatment Licensing, including the federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220) question that comes up when the two share owners.
Staffing an Outpatient Program
A small outpatient program typically needs a clinical director and two to three counselors, and Vermont’s certification tiers are the real reason that stays affordable. Counselors in Vermont’s substance abuse, behavioral disorder, and mental health category had a statewide median of roughly $60,410 a year in BLS OEWS figures for May 2025, just above the $59,350 national median. At those wages, a clinical director with two to three counselors usually means $200,000 to $270,000 a year of clinical payroll before benefits. Most Vermont outpatient clinics aren’t writing a check for that full amount, and the certification tiers are why. Under 26 V.S.A. § 3236a the Office of Professional Regulation certifies Apprentice Addiction Professionals (AAP) and Alcohol and Drug Abuse Counselors (ADC), both of whom work at meaningfully lower wages than a fully independent LADC while accruing the hours their next credential requires. OPR ties both credentials to a DSU certified provider, so they only make sense on a certified program’s payroll. The LADC itself, under § 3236, takes a master’s or doctorate in a human services field, an OPR or IC&RC counselor certification, the approved exam, and 2,000 hours of supervised practice. The lower tiers are spelled out in OPR’s current application instructions. An AAP applicant shows transcripts proving they graduated from or matriculated in a course of study leading to at least an associate degree, 40 hours of substance abuse education completed within five years, employment with a preferred provider, and a passed exam. An ADC applicant on the exam route needs a bachelor’s degree or higher, 270 hours of substance use disorder education, employment with an ADAP certified provider, and 4,000 hours of supervised practice at one hour of supervision for every 40 hours worked. On the DSU side, standard 5.3.1 lets a counselor work if licensed, if holding an ADC certificate, or if they obtain an AAP certificate within 180 days of hire, and standard 5.10.1 requires clinical supervision by a qualified licensed professional at least twice a month. In our experience AAP and ADC counselors under an LADC clinical director is the usual setup. The actual matrix and cost estimate follow once the program model itself is set.
How to Submit Your DSU Certification Application
DSU’s office is Substance Use Programs, Vermont Department of Health, 280 State Drive, Waterbury, VT 05671-8340, phone 802-651-1550, email ahs.vdhdsu@vermont.gov. Ask there for the current application. Section 4.1.1 of the certification rule lists what an initial application must describe, among them the need or gap the program fills, the population and service area, its operating, fiscal and staffing models, its capacity to report data to the Department, and good standing with the Vermont Department of Taxes. The treatment standards say Department of Health representatives visit each service location before a certificate is issued. From what we have seen, the certificate does not come on the day of the visit, so leave room for DSU to review your written policies first. If certification is denied, suspended or revoked, section 8 of the rule gives the program a hearing with the Commissioner or a designee under 3 V.S.A. § 809, and the program does not keep preferred provider status while the appeal runs. The 2020 rule text still names the Board of Health for a further appeal under 18 V.S.A. § 128, but Act 53 of 2023 rewrote § 128. As amended, effective June 8, 2023, the section now sends an appeal of the Commissioner’s decision to the Superior Court within 30 days.
What Delays Vermont Outpatient Applications
These are patterns from our own work, not DSU statements. Owners often assume an outpatient clinic needs no state review at all, then find late that Department funding, or a plan to hire AAP and ADC counselors, puts DSU certification back on the path. Staffing plans also stall when they don’t show who holds which credential, how anyone without one will reach the AAP within 180 days, and how twice-monthly supervision will actually happen. And MAT tracks get built without a written Hub coordination plan or a process for the 48-hour pregnancy referral, which is easy to fix early and slow to fix after a site visit.
Frequently Asked Questions
Does an outpatient SUD program in Vermont need a DAIL facility license?
No. The Therapeutic Community Residence license from DAIL’s Division of Licensing and Protection covers places that treat three or more residents, so an outpatient clinic, IOP included, falls outside it. DSU certification is required when the program receives state or federal funding from the Department, and it is also what lets a clinic hire AAP and ADC counselors.
How long does DSU certification take for an outpatient program?
Our planning range is roughly 5 to 9 months from planning to certification, most of it driven by policy development and scheduling the required DSU site visit. That is our estimate from experience, not a state processing time.
Does Certificate of Need apply to outpatient SUD treatment in Vermont?
Usually not, because of the dollar thresholds. Outpatient therapy programs do fall within the statute’s definition of a health care facility, but since Act 15 of 2025 review applies only to new projects above $10 million in capital cost, $5 million in equipment, or $3 million a year in operating expense for a new service. Most outpatient clinics come in far below those figures.
Setting up DSU certification for a Vermont outpatient program? Reach out here.
Sources
- Vermont Department of Health, Substance Use Disorder Treatment Certification Rule: rule text (effective 01/01/2020) (checked October 7, 2026)
- Vermont Department of Health, DSU: Preferred Provider Substance Use Disorder Treatment Standards (checked October 7, 2026)
- Vermont Department of Health, DSU: Treatment Provider Certification (checked October 7, 2026)
- Vermont Department of Health: Rules Governing Medications for Opioid Use Disorder (effective 5/15/2024) (checked October 7, 2026)
- Vermont Blueprint for Health: Hub and Spoke (checked October 7, 2026)
- 33 V.S.A. § 7102, Therapeutic Community Residence definition (Justia mirror of the Vermont Statutes): § 7102 (checked October 7, 2026)
- DAIL Division of Licensing and Protection: License Application / Reapplication form (checked October 7, 2026)
- 18 V.S.A. § 128, appeals: § 128; Act 53 of 2023 (H.125): bill status and act summary (checked October 7, 2026)
- 18 V.S.A. § 9432, definitions: § 9432 (checked October 7, 2026)
- 18 V.S.A. § 9434, Certificate of Need thresholds: § 9434 (checked October 7, 2026)
- 18 V.S.A. § 9435, exclusions: § 9435 (checked October 7, 2026)
- Act 15 of 2025 (H.96), as enacted: Act 15 (checked October 7, 2026)
- Green Mountain Care Board: Certificate of Need and River Rock Treatment Center filing, GMCB-007-20con (checked October 7, 2026)
- 26 V.S.A. § 3236, LADC eligibility: § 3236; § 3236a, AAP and ADC certification: § 3236a (checked October 7, 2026)
- Vermont Office of Professional Regulation: Alcohol and Drug Abuse Counselor FAQs and Forms and Instructions (checked October 7, 2026)
- 42 CFR 8.11, OTP certification: eCFR § 8.11 (checked October 7, 2026)
- DEA Diversion Control Division: Dear Registrant letter on buprenorphine, January 2023, MATE Act FAQ and MATE training letter (checked October 7, 2026)
- SAMHSA: Waiver Elimination (MAT Act) (checked October 7, 2026)
- 21 CFR 1308.13(c)(7) and 1301.12 (Cornell LII mirror): Ketamine in Schedule III and Separate registration for each location (checked October 9, 2026)
- FDA: SPRAVATO prescribing information and Medication Guide, revised 09/2026 (checked October 9, 2026)
- 11 V.S.A. chapter 3: Incorporation of Professional Persons, §§ 802, 805, 807 (checked October 9, 2026)
- Act 133 of 2026 (H.583): Act as enacted and bill status, governor approved June 15, 2026; H.583 as introduced, proposed § 9531 on practice ownership: bill as introduced (checked October 9, 2026)
- 26 V.S.A. § 1613: APRN transition to practice (checked October 9, 2026)
- Vermont Prescription Monitoring System rule, Code Vt. R. 13-140-069 (Cornell LII mirror): Reporting duties and exemptions (checked October 9, 2026)
- 18 U.S.C. § 220 (Cornell LII mirror): Illegal remunerations for referrals (checked October 9, 2026)

Leave a Reply